MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung

Translated title of the contribution: Mog encephalomyelitis: International recommendations on diagnosis and antibody testing

S. Jarius, F. Paul, O. Aktas, N. Asgari, R. C. Dale, J. De Seze, D. Franciotta, K. Fujihara, A. Jacob, H. J. Kim, I. Kleiter, T. Kümpfel, M. Levy, J. Palace, K. Ruprecht, A. Saiz, C. Trebst, B. G. Weinshenker, B. Wildemann

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Over the past few years, new-generation cellbased assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis,myelitis and brainstemencephalitis, as well as with acute disseminated encephalomyelitis (ADEM) -like presentations. Most experts now consider MOG-IgG-associated encephalomyelitis (MOG-EM) a disease entity in its own right, immunopathogenetically distinct from both classicmultiple sclerosis (MS) and aquaporin-4 (AQP4) -IgG-positive neuromyelitis optica spectrum disorders (NMOSD). Owing to a substantial overlap in clinicoradiological presentation, MOG-EM was often unwittingly misdiagnosed as MS in the past. Accordingly, increasing numbers of patients with suspected or establishedMS are currently being tested for MOG-IgG. However, screening of large unselected cohorts for rare biomarkers can significantly reduce the positive predictive value of a test. To lessen the hazard of overdiagnosing MOG-EM, which may lead to inappropriate treatment,more selective criteria for MOG-IgG testing are urgently needed. In this paper, we propose indications for MOG-IgG testing based on expert consensus. In addition, we give a list of conditions atypical for MOG-EM (“red flags”) that should prompt physicians to challenge a positive MOG-IgG test result. Finally, we provide recommendations regarding assay methodology, specimen sampling and data interpretation, and propose for the first time diagnostic criteria for MOG-EM.

Translated title of the contributionMog encephalomyelitis: International recommendations on diagnosis and antibody testing
Original languageGerman
Pages (from-to)1388-1399
Number of pages12
Issue number12
StatePublished - 2018


  • Antibody testing
  • Consensus recommendations
  • Diagnosis
  • Multiple sclerosis (MS)
  • Myelin oligodendrocyte glycoprotein (MOG) antibodies
  • Myelitis
  • Neuromyelitis optica spectrum disorders (NMOSD)
  • Optic neuritis (ON)

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Mog encephalomyelitis: International recommendations on diagnosis and antibody testing'. Together they form a unique fingerprint.

Cite this